AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sight Sciences, Inc. Director's Dealing 2021

Jul 15, 2021

33763_dirs_2021-07-14_dadf479c-742b-41c3-9b47-97e910f07bdc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Sight Sciences, Inc. (SGHT)
CIK: 0001531177
Period of Report: 2021-07-14

Reporting Person: HAYDEN JEREMY B. (Chief Legal Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Ownership
Stock Option (Right to Buy)	$1.96	2030-05-10	Common Stock (80000)	Direct
Stock Option (Right to Buy)	$1.96	2030-07-28	Common Stock (16000)	Direct
Stock Option (Right to Buy)	$10.96	2031-05-24	Common Stock (70000)	Direct

Footnotes

F1: The option vests and becomes exercisable as to 25% of the underlying securities on April 20, 2021 and in 36 equal monthly installments thereafter.

F2: The option vests and becomes exercisable in 48 substantially equal monthly installments commencing on August 30, 2020.

F3: The option vests and becomes exercisable in 48 substantially equal monthly installments commencing on June 24, 2021.